title: Detection of molecular alterations in methamphetamine-activated Fos-expressing neurons from a single rat dorsal striatum using fluorescence-activated cell sorting (FACS).
abstract: Methamphetamine and other drugs activate a small proportion of all neurons in the brain. We previously developed a fluorescence-activated cell sorting (FACS)-based method to characterize molecular alterations induced selectively in activated neurons that express the neural activity marker Fos. However, this method requires pooling samples from many rats. We now describe a modified FACS-based method to characterize molecular alterations in Fos-expressing dorsal striatal neurons from a single rat using a multiplex pre-amplification strategy. Fos and NeuN (a neuronal marker) immunohistochemistry indicate that 5-6% of dorsal striatum neurons were activated 90 min after acute methamphetamine injections (5 mg/kg, i.p.) while less than 0.5% of neurons were activated by saline injections. We used FACS to separate NeuN-labeled neurons into Fos-positive and Fos-negative neurons and assessed mRNA expression using RT-qPCR from as little as five Fos-positive neurons. Methamphetamine induced 3-20-fold increases of immediate early genes arc, homer-2, c-fos, fosB, and its isoforms (ΔfosB and a novel isoform ΔfosB-2) in Fos-positive but not Fos-negative neurons. Immediate early gene mRNA induction was 10-fold lower or absent when assessed in unsorted samples from single dorsal striatum homogenates. Our modified method makes it feasible to study unique molecular alterations in neurons activated by drugs or drug-associated cues in complex addiction models. Methamphetamine and other drugs activate a small proportion of all neurons in the brain. We here report an improved method to characterize molecular alterations induced selectively in activated neurons that express the neural activity marker Fos. We used FACS along with targeted PCR pre-amplification to assess acute methamphetamine-induced gene expression from as few as 5 Fos-expressing neurons from a single rat dorsal striatum. Methamphetamine induced 3-20-fold increases of immediate early genes (IEGs) in Fos-positive but not Fos-negative neurons. Targeted PCR pre-amplification makes it feasible to study unique molecular alterations in neurons activated by drugs or drug-associated cues in complex addiction models.
authors.affiliation: NIDA Intramural Research Program, NIH/DHHS, Baltimore, Maryland, USA.
authors.forename: Qing-Rong
authors.initials: QR
authors.lastname: Liu
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Rubio
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Bossert
authors.forename: Nathan J
authors.initials: NJ
authors.lastname: Marchant
authors.forename: Sanya
authors.initials: S
authors.lastname: Fanous
authors.forename: Xingyu
authors.initials: X
authors.lastname: Hou
authors.forename: Yavin
authors.initials: Y
authors.lastname: Shaham
authors.forename: Bruce T
authors.initials: BT
authors.lastname: Hope
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D003342:Corpus Striatum / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D005434:Flow Cytometry / Q000379:methods*; D005786:Gene Expression Regulation; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D008969:Molecular Sequence Data; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis* / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D008694:Methamphetamine
keywords: flow cytometry; gene expression; immediate early genes
references.citation: J Neurobiol. 1995 Mar;26(3):403-12
references.pmid: 7775973
references.citation: Nat Neurosci. 1999 Dec;2(12):1120-4
references.pmid: 10570490
references.citation: Neuron. 1994 Nov;13(5):1235-44
references.pmid: 7946359
references.citation: Annu Rev Neurosci. 1991;14:421-51
references.pmid: 1903243
references.citation: Psychopharmacology (Berl). 2013 Oct;229(3):453-76
references.pmid: 23685858
references.citation: Nat Neurosci. 2011 Apr;14(4):420-2
references.pmid: 21336273
references.citation: Curr Opin Neurobiol. 2004 Dec;14(6):763-8
references.pmid: 15582381
references.citation: J Neurosci. 1998 Apr 15;18(8):3098-115
references.pmid: 9526026
references.citation: Nat Rev Neurosci. 2001 Feb;2(2):119-28
references.pmid: 11252991
references.citation: Brain Res Mol Brain Res. 2004 Dec 20;132(2):146-54
references.pmid: 15582154
references.citation: J Neurosci Methods. 2012 Jan 15;203(1):10-8
references.pmid: 21911005
references.citation: Nat Neurosci. 2002 Nov;5 Suppl:1076-9
references.pmid: 12403990
references.citation: Development. 1992 Sep;116(1):201-11
references.pmid: 1483388
references.citation: Cell. 1991 Feb 22;64(4):751-9
references.pmid: 1900040
references.citation: J Neurosci. 2012 Jun 20;32(25):8480-90
references.pmid: 22723688
references.citation: Nat Rev Neurosci. 2011 Oct 05;12(11):685-700
references.pmid: 21971065
references.citation: J Neurosci. 2012 Aug 22;32(34):11600-9
references.pmid: 22915104
references.citation: Nat Neurosci. 2006 Mar;9(3):443-52
references.pmid: 16491081
references.citation: J Neurosci. 1997 Jul 1;17(13):4933-41
references.pmid: 9185531
references.citation: J Neurosci. 1994 Jul;14(7):4318-28
references.pmid: 8027782
references.citation: J Neurosci. 2012 Apr 4;32(14):4982-91
references.pmid: 22492053
references.citation: Eur J Neurosci. 2008 Jan;27(1):202-12
references.pmid: 18093170
references.citation: Nature. 1999 Sep 16;401(6750):272-6
references.pmid: 10499584
references.citation: Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1923-8
references.pmid: 23319622
references.citation: Int Rev Neurobiol. 2009;89:1-35
references.pmid: 19900613
references.citation: Neuroscience. 2007 May 11;146(2):525-36
references.pmid: 17360123
references.citation: Nat Neurosci. 2006 Feb;9(2):205-11
references.pmid: 16415864
references.citation: Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):141-53
references.pmid: 9716936
references.citation: Neuroreport. 1997 Jul 28;8(11):2581-5
references.pmid: 9261831
references.citation: J Neurosci. 2011 Mar 16;31(11):4251-9
references.pmid: 21411666
references.citation: Psychopharmacology (Berl). 2012 Dec;224(4):559-71
references.pmid: 22790874
references.citation: Neuropharmacology. 2004;47 Suppl 1:61-79
references.pmid: 15464126
references.citation: Nat Neurosci. 2009 Aug;12(8):1069-73
references.pmid: 19620976
references.citation: Neuropsychopharmacology. 2011 Jan;36(2):497-510
references.pmid: 20962767
references.citation: Eur J Neurosci. 2006 Aug;24(3):867-75
references.pmid: 16930414
references.citation: J Neurochem. 2013 Jan;124(1):100-8
references.pmid: 23113797
references.citation: Cell Calcium. 2007 Oct-Nov;42(4-5):363-71
references.pmid: 17618683
references.citation: Nat Neurosci. 2005 Nov;8(11):1437-9
references.pmid: 16251983
references.citation: Nat Rev Neurosci. 2013 Nov;14(11):743-54
references.pmid: 24088811
references.citation: Mol Pharmacol. 1995 Nov;48(5):880-9
references.pmid: 7476919
references.citation: J Neurosci. 2000 Jan 15;20(2):798-805
references.pmid: 10632609
references.citation: Synapse. 2008 May;62(5):358-69
references.pmid: 18293355